Position in CDNA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,285,977
New position
Shares Held
45,122
first reported quarter
Ownership
0.087%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#97
of 225 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Susquehanna Portfolio Strategies, LLC holds $96,079,544 across 8 Diagnostics & Research names. CDNA ranks #7 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | A |
Agilent Technologies, Inc.
|
350,725 | $46,586,801 | |
| 2 | GH |
Guardant Health, Inc.
|
155,346 | $23,306,560 | |
| 3 | DGX |
Quest Diagnostics Inc
|
60,404 | $12,802,627 | |
| 4 | TWST |
Twist Bioscience Corp
|
54,617 | $5,618,996 | |
| 5 | GRAL |
GRAIL, Inc.
|
71,088 | $4,853,177 | |
| 6 | PSNL |
Personalis, Inc.
|
121,299 | $1,625,406 | |
| 7 | CDNA |
CareDx, Inc.
This page
|
45,122 | $1,285,977 | |
| 8 | ADPT |
Adaptive Biotechnologies Corp
|
54,788 | $0 |
All Filings in CDNA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,285,977 | 45,122 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||